Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Judge

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Kidney International Reports|November 24, 2025
Glucose Interference in Urine Biomarkers and Implications for Sodium-Glucose Cotransporter 2 InhibitionGreco B Malijan, Daniel Chapman, Stewart Moffat, et al.
Journal of Public Health Policy|June 23, 2007
Applying an equity lens to tobacco-control policies and their uptake in six Western-European countriesK Giskes, A E Kunst, C Ariza, et al.
Hypertension (Dallas, Tex. : 1979)|December 29, 2016
Evidence for Reverse Causality in the Association Between Blood Pressure and Cardiovascular Risk in Patients With Chronic Kidney DiseaseWilliam Herrington, Natalie Staplin, Parminder K Judge, et al.
Journal of the American Society of Nephrology : JASN|May 4, 2017
Biliary Tract and Liver Complications in Polycystic Kidney DiseaseParminder K Judge, Charlie H S Harper, Benjamin C Storey, et al.
Hypertension (Dallas, Tex. : 1979)|September 9, 2022
Determining the Relationship Between Blood Pressure, Kidney Function, and Chronic Kidney Disease: Insights From Genetic EpidemiologyNatalie Staplin, William G Herrington, Federico Murgia, et al.
Journal of Epidemiology and Community Health|April 16, 2005
Trends in smoking behaviour between 1985 and 2000 in nine European countries by educationK Giskes, A E Kunst, J Benach, et al.
Circulation|July 14, 2018
Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney DiseaseRichard Haynes, Parminder K Judge, Natalie Staplin, et al.
Cell Reports|August 10, 2024
Type I interferon governs immunometabolic checkpoints that coordinate inflammation during Staphylococcal infectionMack B Reynolds, Benjamin Klein, Michael J McFadden, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 15, 2024
Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trialKaitlin J Mayne, Rebecca J Sardell, Natalie Staplin, et al.
Inflammatory Bowel Diseases|January 30, 2025
Generalizability of Randomized Controlled Trials to Routine Clinical Care in Ulcerative ColitisTarun Chhibba, Alexandra Frolkis, Levi R Stein, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Kidney International Reports|November 24, 2025
Glucose Interference in Urine Biomarkers and Implications for Sodium-Glucose Cotransporter 2 InhibitionGreco B Malijan, Daniel Chapman, Stewart Moffat, et al.
Journal of Public Health Policy|June 23, 2007
Applying an equity lens to tobacco-control policies and their uptake in six Western-European countriesK Giskes, A E Kunst, C Ariza, et al.
Hypertension (Dallas, Tex. : 1979)|December 29, 2016
Evidence for Reverse Causality in the Association Between Blood Pressure and Cardiovascular Risk in Patients With Chronic Kidney DiseaseWilliam Herrington, Natalie Staplin, Parminder K Judge, et al.
Journal of the American Society of Nephrology : JASN|May 4, 2017
Biliary Tract and Liver Complications in Polycystic Kidney DiseaseParminder K Judge, Charlie H S Harper, Benjamin C Storey, et al.
Hypertension (Dallas, Tex. : 1979)|September 9, 2022
Determining the Relationship Between Blood Pressure, Kidney Function, and Chronic Kidney Disease: Insights From Genetic EpidemiologyNatalie Staplin, William G Herrington, Federico Murgia, et al.
Journal of Epidemiology and Community Health|April 16, 2005
Trends in smoking behaviour between 1985 and 2000 in nine European countries by educationK Giskes, A E Kunst, J Benach, et al.
Circulation|July 14, 2018
Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney DiseaseRichard Haynes, Parminder K Judge, Natalie Staplin, et al.
Cell Reports|August 10, 2024
Type I interferon governs immunometabolic checkpoints that coordinate inflammation during Staphylococcal infectionMack B Reynolds, Benjamin Klein, Michael J McFadden, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 15, 2024
Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trialKaitlin J Mayne, Rebecca J Sardell, Natalie Staplin, et al.
Inflammatory Bowel Diseases|January 30, 2025
Generalizability of Randomized Controlled Trials to Routine Clinical Care in Ulcerative ColitisTarun Chhibba, Alexandra Frolkis, Levi R Stein, et al.
Pageof 11